The global cholera vaccines sector is entering a strong growth phase as rising cholera cases, increasing international travel, expanding immunization programs, and greater vaccine production create new opportunities. The sector was valued at USD 103.99 million in 2025, reached USD 114.43 million in 2026, and is projected to reach USD 270.71 million by 2035, expanding at a CAGR of 10.05% from 2026 to 2035.
Key Trends
Cholera vaccines are an important tool for reducing the risk of cholera, particularly in regions where transmission occurs frequently. Oral cholera vaccines (OCVs) stimulate immune responses in the intestine and are used alongside clean water, sanitation, and proper hygiene.
The rising incidence of cholera in developing and underdeveloped countries is one of the major factors supporting demand. Increased domestic and international travel is also contributing, as travelers visiting cholera-prone regions may face greater exposure to contaminated food and water.
Another important trend is the expansion of vaccine production. Manufacturers are investing in advanced technologies and increasing production capacity to improve global vaccine availability. In March 2024, the International Vaccine Institute began technology transfer of a simplified oral cholera vaccine to Biological E. in India, supporting the production of affordable vaccines.
Role of AI
Artificial intelligence is emerging as a valuable technology across the cholera vaccine ecosystem. AI and machine learning can support vaccine research by helping researchers identify antigens, predict immune responses, and optimize vaccine candidates.
AI can also improve manufacturing through automated process monitoring, quality control, and predictive analytics. In addition, intelligent supply-chain systems can help monitor storage and transportation conditions, which is particularly important for vaccines requiring controlled temperatures.
Key Segment Insights
The killed oral O1 and O139 segment held a leading position in 2025 because these vaccines offer stability and easier storage and transportation.
By product, Dukoral accounted for the largest share in 2025. Meanwhile, Vaxchora is expected to experience the fastest growth, supported by increasing travel to regions with high cholera transmission.
By distribution channel, hospital pharmacies led in 2025 due to trained healthcare professionals, appropriate storage facilities, and expanding immunization programs.
Regional Outlook
North America held the leading position in 2025, supported by advanced healthcare infrastructure, strong research capabilities, and high international travel activity.
Asia-Pacific is expected to grow at the fastest pace through 2035. Growing vaccine manufacturing capabilities, increasing awareness, and the presence of major vaccine producers such as Bharat Biotech, Biological E., and EuBiologics are supporting regional expansion.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/5405
Future Outlook
The future of cholera vaccines will be shaped by higher production capacity, improved vaccine technologies, stronger public-health programs, AI-driven research, and expanding international cooperation. As governments and healthcare organizations focus on preventing outbreaks and improving vaccine access, the sector is expected to maintain strong growth through 2035.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium